Datacubed Health is a technology company focused on making clinical trials more efficient.
Datacubed Health appointed Marc Eigner as executive chairman of the board. Eigner currently serves as an operating partner at the private equity group Berenson Capital.
Prior to joining Datacubed Health's board, Eigner co-founded Polaris, which was acquired by IQVIA in 2017.
PD-L1 IHC 22C3 pharmD approved to help identify patients who may be eligible to receive treatment with pembrolizumab (Keytruda) to treat gastric or gastroesophageal junction adenocarcinoma.